Considerable on MSN
GSK buys Rapt in $2.2B deal
GSK agreed to acquire Rapt Therapeutics for $2.2 billion on Tuesday, a move that ...
GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal antibody that targets interleukin-5, as an add-on ...
There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...
GSK Plc (NYSE:GSK) has filed a lawsuit against Moderna, Inc. (NASDAQ:MRNA) and its affiliates, alleging that Moderna’s mRNA vaccines infringe on patents developed by GSK. According to GSK, the ...
GSK plc (NYSE:GSK) is included among the 11 Best FTSE Dividend Stocks to Buy Right Now. Image by Alexsander-777 from Pixabay GSK plc (NYSE:GSK) is a major global healthcare company with operations ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
GSK has brought its message about the risks of antimicrobial resistance (AMR) to commuters in London. The drugmaker worked with its partner the Fleming Initiative to tell people traveling through ...
GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified, leading to a "Strong Buy" rating. The company’s diversified portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results